1. Home
  2. REED vs ADVB Comparison

REED vs ADVB Comparison

Compare REED & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reed's Inc.

REED

Reed's Inc.

HOLD

Current Price

$0.82

Market Cap

9.1M

Sector

N/A

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$8.10

Market Cap

8.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REED
ADVB
Founded
1987
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
8.6M
IPO Year
2009
2023

Fundamental Metrics

Financial Performance
Metric
REED
ADVB
Price
$0.82
$8.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.7K
176.0K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
5.21
Revenue
$34,065,000.00
N/A
Revenue This Year
$18.74
N/A
Revenue Next Year
$18.00
N/A
P/E Ratio
N/A
$1.54
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.19
52 Week High
$5.97
$24.23

Technical Indicators

Market Signals
Indicator
REED
ADVB
Relative Strength Index (RSI) 52.80 49.20
Support Level $0.76 $3.95
Resistance Level $1.42 $9.50
Average True Range (ATR) 0.11 1.02
MACD 0.04 -0.14
Stochastic Oscillator 69.59 56.49

Price Performance

Historical Comparison
REED
ADVB

About REED Reed's Inc.

Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: